Selegiline: current perspectives on issues related to neuroprotection and mortality.
Olanow
C W
CW
Department of Neurology, Mount Sinai School of Medicine, New York, NY 10029, USA.
D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000401:mortality; D012642:Selegiline / Q000627:therapeutic use*; D016019:Survival Analysis
D018696:Neuroprotective Agents; D012642:Selegiline